Affiliation:
1. 1Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraidah KSA.
2. 2Prince Sultan cardiac center, King Fahad Specialist Hospital, Buraydah, QHC, MOH,KSA
3. 3King Saud Hospital, Unaizah, QHC, MOH,KSA.
4. 4Al-Bukayria General Hospital, QHC, MOH,KSA.
Abstract
Acute coronary syndrome (ACS) which known as subcategory of coronary heart disease is considered a major cause of death. In Saudi Arabia, the prevalence of ACS is 8.2%. Early recognition of risk factors (RFs) associated with ACS is essential to prevent its progression. Therefore, the goals of this study is to estimate the prevalence of cardiovascular RFs among ACS patients and to appraise its association with the development of ACS. This retrospective multi-center cross-sectional study involved 170 patients admitted to Prince Sultan cardiac center, King Saud Hospital, and Bukayriyah General Hospital in Al Qassim, KSA. The participants categorized into three groups UA, NSTEMI, and STEMI. Patients with stable angina or previous MI were excluded from the study. 73.5% were males and 26.5% were females with a mean age of 58.2 ± 11.9. The distribution of ACS subtypes was 51.2%, 27.6%, and 21.2% for STEMI, NSTEMI and UA, respectively. The most common RFs were diabetes mellitus (DM), hypertension (66% each), and dyslipidemia (58%). The prevalence of RFs among STEMI group was 65.6% active smokers, 54.5% dyslipidemia, and 52.2% ischemic heart disease (IHD). On the other hand, in NSTEMI group hypertension and DM were nearly the same (32% & 30% respectively), however family history of IHD was 42.9%. UA revealed a strong association with IHD and family history of IHD (30.4%, 28.6%, respectively).To conclude, most of ACS patients presented with STEMI followed by NSTEMI and the least with UA. Among the cardiovascular risk factors, HTN, DM, and dyslipidemia, were presented in more than half of the patients which strongly suggests an association with developing ACS.
Publisher
Oriental Scientific Publishing Company
Reference37 articles.
1. 1. Barstow C, Rice M, McDivitt JD. Acute coronary syndrome: Diagnostic evaluation. Am Fam Physician. 2017;95(3):170–7.
2. 2. Mohammed S, Mohammed A, Alharbi S, Algorinees R, Alghuraymil AA, Alsaif M. Incidence of Acute Coronary Syndrome (ACS). In: EUROPEAN ACADEMIC RESEARC.
3. 3. Amsterdam EA, Wenger NK, Brindis RG, De C, Ganiats TG, Dr H. AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: A report of the American college of cardiology/American heart association task force on practice guidelines. Circulation. 2014;130(25):e344-426.
4. 4. Singh A, Museedi AS, Grossman SA. Acute Coronary Syndrome. In: FL: StatPearls Publishing. 2021.
5. 5. Fanaroff AC, Rymer JA, Goldstein SA. JAMA patient page. Acute coronary syndrome. JAMA [Internet]. 2015;314(18):1990. Available from: http://dx.doi.org/10.1001/jama.2015.12743